Company expects up to six-month review period per FDA guidelines New longer-term clinical data demonstrating durable positive brain biochemical ...
ACM impedes the heart from pumping blood to the rest of the body, and is a leading cause of sudden cardiac death in young ...
Market OverviewThe global cell and gene therapy market is undergoing rapid and transformative growth, reflecting its increasing importance in modern healthcare.The market is projected to expand at a ...
Gene Expression Data Show Direct Impact on the Core Biology of IPF ...
Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, today announced an upgrade to its Viral Clearance ...
Services Market OverviewThe global contract research organization services market is poised to register steady growth at an estimated rate of around 9% over the next five years, reflecting the ...
Raw materials play a critical role in cell therapy manufacturing. Choosing suboptimal materials at any stage of development ...
Detailed price information for Taysha Gene Therapies Inc (TSHA-Q) from The Globe and Mail including charting and trades.
Charles River Laboratories International, Inc. and Gazi University Faculty of Medicine, today announced a gene therapy contract development and manufacturing organization (CDMO) collaboration, ...
The Adelson Collection Center has always been known for its signature warm, inviting environment and concierge-style donor experience. With the increased capacity, more donors can be scheduled each ...
The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...
Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene therapies while helping scientists to streamline quality-control processes with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results